Korevaar 2003.

Methods	Method of random allocation: not described Unclear whether investigators, outcome assessors or data analysis was blinded. It is not stated whether participants were blinded but the nature of the interventions makes it unlikely Description of withdrawals/dropouts: not mentioned Analysis on intention to treat basis: unclear Completeness of follow‐up: unclear Duration of follow‐up 5 years
Participants	38 patients receiving dialysis treatment for ESKD. 18 randomised to HD and 20 to PD Inclusion criteria: Exclusion criteria: Patients from 38 Dutch dialysis units with no medical, social or logistic objections. Further details not provided Proportion male: 58% Age (mean, SD) Overall 59 (12) Primary kidney disease: Overall 24% diabetes mellitus, 18% renal vascular disease
Interventions	PD vs HD
Outcomes	Quality of life (measured in quality adjusted life years [QALYs] at 2 years) Survival (at five years)
Notes	Trial recruitment stopped early due to problems with recruitment. QALYs are measure of effectiveness used in economic evaluations. further quality assessment is described in the additional tables
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear